exendin 4 tirzepatide Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond Structures of natural exendin-4, GLP-1

A 2025 preclinical bioRxiv preprint reported that low-dose semaglutide produced cardiac and hepatic benefits independent of weight loss in obese rats with HFpEF, but this is animal data and has not been replicated in humans (bioRxiv preprint, 2025)

This can lead to increased gas production as food spends more time in the digestive tract and changes in eating habits that might not always favor easy digestion

Continuing to gain and lose weight quicklyalso known as weight cyclingcan also cause severe stress on the body and affect your health

Study data can be requested after publication through the corresponding author

Ved sammenligne flere aktrer side om side fr du ofte et klarere bilde av hva som passer deg best